wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38100787-9788DA62-67DA-4DD2-96FE-D5C8C1B35721
Q38100787-9788DA62-67DA-4DD2-96FE-D5C8C1B35721
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100787-9788DA62-67DA-4DD2-96FE-D5C8C1B35721
Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia.
P2860
Q38100787-9788DA62-67DA-4DD2-96FE-D5C8C1B35721
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100787-9788DA62-67DA-4DD2-96FE-D5C8C1B35721
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b5faac1ae208278ca7d461faf4f4132ae6c058b
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.